BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31487937)

  • 1. Prevalence, Type, and Molecular Spectrum of
    Pinna V; Daniele P; Calcagni G; Mariniello L; Criscione R; Giardina C; Lepri FR; Hozhabri H; Alberico A; Cavone S; Morella AT; Mandile R; Annunziata F; Di Giosaffatte N; D'Asdia MC; Versacci P; Capolino R; Strisciuglio P; Giustini S; Melis D; Digilio MC; Tartaglia M; Marino B; De Luca A
    Genes (Basel); 2019 Sep; 10(9):. PubMed ID: 31487937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased rate of missense/in-frame mutations in individuals with NF1-related pulmonary stenosis: a novel genotype-phenotype correlation.
    Ben-Shachar S; Constantini S; Hallevi H; Sach EK; Upadhyaya M; Evans GD; Huson SM
    Eur J Hum Genet; 2013 May; 21(5):535-9. PubMed ID: 23047742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome.
    De Luca A; Bottillo I; Sarkozy A; Carta C; Neri C; Bellacchio E; Schirinzi A; Conti E; Zampino G; Battaglia A; Majore S; Rinaldi MM; Carella M; Marino B; Pizzuti A; Digilio MC; Tartaglia M; Dallapiccola B
    Am J Hum Genet; 2005 Dec; 77(6):1092-101. PubMed ID: 16380919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
    Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
    J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome.
    Thiel C; Wilken M; Zenker M; Sticht H; Fahsold R; Gusek-Schneider GC; Rauch A
    Am J Med Genet A; 2009 Jun; 149A(6):1263-7. PubMed ID: 19449407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the clinical phenotype of RASopathies in 38 Turkish patients, including the rare LZTR1, RAF1, RIT1 variants, and large deletion in NF1.
    Uludağ Alkaya D; Lissewski C; Yeşil G; Zenker M; Tüysüz B
    Am J Med Genet A; 2021 Dec; 185(12):3623-3633. PubMed ID: 34184824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A variable combination of features of Noonan syndrome and neurofibromatosis type I are caused by mutations in the NF1 gene.
    Hüffmeier U; Zenker M; Hoyer J; Fahsold R; Rauch A
    Am J Med Genet A; 2006 Dec; 140(24):2749-56. PubMed ID: 17103458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.
    Witkowski L; Dillon MW; Murphy E; S Lebo M; Mason-Suares H
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1180. PubMed ID: 32107864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.
    Ekvall S; Sjörs K; Jonzon A; Vihinen M; Annerén G; Bondeson ML
    Am J Med Genet A; 2014 Mar; 164A(3):579-87. PubMed ID: 24357598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types.
    Kang E; Kim YM; Seo GH; Oh A; Yoon HM; Ra YS; Kim EK; Kim H; Heo SH; Kim GH; Osborn MJ; Tolar J; Yoo HW; Lee BH
    J Hum Genet; 2020 Jan; 65(2):79-89. PubMed ID: 31776437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1.
    Nyström AM; Ekvall S; Allanson J; Edeby C; Elinder M; Holmström G; Bondeson ML; Annerén G
    Clin Genet; 2009 Dec; 76(6):524-34. PubMed ID: 19845691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?
    Alkindy A; Chuzhanova N; Kini U; Cooper DN; Upadhyaya M
    Hum Genomics; 2012 Aug; 6(1):12. PubMed ID: 23244495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital heart diseases in children with Noonan syndrome: An expanded cardiac spectrum with high prevalence of atrioventricular canal.
    Marino B; Digilio MC; Toscano A; Giannotti A; Dallapiccola B
    J Pediatr; 1999 Dec; 135(6):703-6. PubMed ID: 10586172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of NF1 mutations in Korean patients with neurofibromatosis type 1.
    Jeong SY; Park SJ; Kim HJ
    J Korean Med Sci; 2006 Feb; 21(1):107-12. PubMed ID: 16479075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatosis type 1 and infantile spasms.
    Ruggieri M; Iannetti P; Clementi M; Polizzi A; Incorpora G; Spalice A; Pavone P; Praticò AD; Elia M; Gabriele AL; Tenconi R; Pavone L
    Childs Nerv Syst; 2009 Feb; 25(2):211-6. PubMed ID: 18802710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotype-Genotype Correlation in Children with Neurofibromatosis Type 1.
    Barrea C; Vaessen S; Bulk S; Harvengt J; Misson JP
    Neuropediatrics; 2018 Jun; 49(3):180-184. PubMed ID: 29471550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation spectrum of NF1 and clinical characteristics in 78 Korean patients with neurofibromatosis type 1.
    Ko JM; Sohn YB; Jeong SY; Kim HJ; Messiaen LM
    Pediatr Neurol; 2013 Jun; 48(6):447-53. PubMed ID: 23668869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and spectrum of NF1 mutations in 12 unrelated Chinese families with neurofibromatosis type 1.
    Mao B; Chen S; Chen X; Yu X; Zhai X; Yang T; Li L; Wang Z; Zhao X; Zhang X
    BMC Med Genet; 2018 Jun; 19(1):101. PubMed ID: 29914388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation.
    Rojnueangnit K; Xie J; Gomes A; Sharp A; Callens T; Chen Y; Liu Y; Cochran M; Abbott MA; Atkin J; Babovic-Vuksanovic D; Barnett CP; Crenshaw M; Bartholomew DW; Basel L; Bellus G; Ben-Shachar S; Bialer MG; Bick D; Blumberg B; Cortes F; David KL; Destree A; Duat-Rodriguez A; Earl D; Escobar L; Eswara M; Ezquieta B; Frayling IM; Frydman M; Gardner K; Gripp KW; Hernández-Chico C; Heyrman K; Ibrahim J; Janssens S; Keena BA; Llano-Rivas I; Leppig K; McDonald M; Misra VK; Mulbury J; Narayanan V; Orenstein N; Galvin-Parton P; Pedro H; Pivnick EK; Powell CM; Randolph L; Raskin S; Rosell J; Rubin K; Seashore M; Schaaf CP; Scheuerle A; Schultz M; Schorry E; Schnur R; Siqveland E; Tkachuk A; Tonsgard J; Upadhyaya M; Verma IC; Wallace S; Williams C; Zackai E; Zonana J; Lazaro C; Claes K; Korf B; Martin Y; Legius E; Messiaen L
    Hum Mutat; 2015 Nov; 36(11):1052-63. PubMed ID: 26178382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
    Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
    JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.